• Science That Shows

Our Publications

Publishing to Advance Clinical Research

As a science-driven company, we continuously publish scientific publications in high-impact journals, and contribute with congress-abstracts with preliminary data.

Please feel free to contact our Science-team if you have questions or comments to our publications, or proposals for new scientific collaborations: science@blueskincro.com 

Select categories
Select categories
Select years
Select years
Select authors
Select authors
Select journals
Select journals

Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial

Osteoarthritis (OA) development programmes face challenges due to discordance between structural changes and symptoms. A novel cathepsin-K inhibitor, MIV-711, recently reported structural benefits, but did not demonstrate a significant difference from placebo in symptoms. Previous work suggests that pain from non-target joints may confound OA pain outcomes. We therefore conducted an exploratory analysis in participants with predominantly unilateral knee pain from the MIV-711-201 trial.
Linkedin-in

© 2025 blueskincro.com

Useful links
Sanos Group
Legal & Privacy